HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Data Supplement Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flusser, H. Articles by Kure, S. Search for Related Content PubMed PubMed Citation Articles by Flusser, H. Articles by Kure, S.

Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation

From the Zusman Child Development Center (Drs. Flusser and Galil), Pediatric Division, Soroka University Medical Center and Ben-Gurion University of the Negev, Beer Sheva, Israel; Department of Clinical Biochemistry (Dr. Korman), Hadassah–Hebrew University Medical Center, Jerusalem, Israel; Department of Medical Genetics (Drs. Sato, Matsubara, and Kure), Tohoku University School of Medicine, Sendai, Japan.

Address correspondence and reprint requests to Dr. Stanley H. Korman, Department of Clinical Biochemistry, Hadassah–Hebrew University Medical Center, POB 12000, Jerusalem 91120, Israel; e-mail: korman{at}hadassah.org.il

Background: Classic neonatal-onset glycine encephalopathy (GE) is devastating and life threatening. Milder, later onset variants have been reported but were usually sporadic and incompletely defined.

Objective: To determine the clinical and biochemical phenotype and molecular basis of mild GE in nine children from a consanguineous Israeli Bedouin kindred.

Methods: Genomic DNA was screened for GLDC, AMT, and GCSH gene mutations. GLDC expression in lymphoblasts was studied by Northern blot and reverse transcriptase PCR analysis.

Results: Clinical features included hypotonia, abnormal movements, convulsions, and moderate mental retardation with relative sparing of gross motor function, activities of daily living skills, and receptive language. Aggression and irritability were prominent. CSF-to-plasma glycine ratio was mildly to moderately elevated. All nine patients were homozygous and their parents heterozygous for a novel, translationally silent GLDC exon 22 transversion c.2607C>A. Lymphoblast GLDC mRNA levels were considerably reduced. Three aberrantly spliced cDNA species were identified: exon 22 and exon 22 to 23 skipping, and insertion of an 87-base pair cryptic exon. Homozygosity for c.2607C>A was also identified in an unrelated but haplotypically identical patient with an unusually favorable outcome despite severe neonatal-onset GE. Mutation analysis enabled prenatal diagnosis of three unaffected and one affected pregnancies.

Conclusions: The mutation in this kindred led to missplicing and reduced GLDC (glycine decarboxylase) expression. The 4 to 6% of normally spliced GLDC mRNA in the patients may account for their relatively favorable clinical outcome compared with patients with classic glycine encephalopathy.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the April 26 issue to find the title link for this article.

*These authors contributed equally to this work.

Received June 18, 2004. Accepted in final form December 23, 2004.

This article has been cited by other articles:

				J. Kanno, T. Hutchin, F. Kamada, A. Narisawa, Y. Aoki, Y. Matsubara, and S. Kure Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia J. Med. Genet., March 1, 2007; 44(3): e69 - e69. [Abstract] [Full Text] [PDF]